Postessential Thrombocythemia (Post-ET) Myelofibrosis
1 clinical trials · Condition
◉ Watch Postessential Thrombocythemia (Post-ET) Myelofibrosis
| Record | Firm | Date |
|---|---|---|
| Momelotinib in Transfusion-Dependent Adults With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF) (NCT02515630) | Sierra Oncology LLC - a GSK company | 2016-01-29 |
Track Postessential Thrombocythemia (Post-ET) Myelofibrosis automatically
Every clearance here is in the API, with alerts when new ones post.